Medifast (MED) Tops Q3 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Imperial Capital Downgrades Medifast (MED) to In-Line
November 7, 2014 6:45 AM ESTImperial Capital downgraded Medifast (NYSE: MED) from Outperform to In-Line with a price target of $32.00 (from $34.00).
Analyst Mitchell Pinheiro comments, "Our price target is about 3% below the recent share price. Our In-Line rating is based on our lower earnings forecast for 2015 which incorporates more subdued growth in the Take Shape For Life segment, the expectation for a flat... More
